Navigation Links
Hypertension Drug Adherence Associated with Fewer Hospitalizations and Lower Medical Costs but Increased Total Care Costs
Date:4/18/2012

SAN FRANCISCO, April 18, 2012 /PRNewswire/ -- Although adherence to hypertension medications was significantly associated with lower hospitalization rates, the total costs of care are higher for adherent patients than for patients who were deemed "non-adherent," according to a new study from pharmacy benefit manager Prime Therapeutics (Prime) that will be presented this week at the Academy of Managed Care Pharmacy (AMCP)'s 24th Annual Meeting & Expo in San Francisco.

The study found patients who were adherent to their hypertension medication had significantly associated lower hospitalization rates, although the higher drug expenses offset the lower medical costs resulting in a higher total cost of care. This result, according to the authors, differs from previous research showing lower hospitalization rates led to lower total costs, and may be due to population differences, including younger age.

Prime set out to compare one year of all-cause hospitalization rates, medical costs and pharmacy costs among patients who were adherent and non-adherent to hypertension medications. Working with the University of Minnesota College of Pharmacy, Data Intelligence Inc. of Eden Prairie, Minn., and one of its Blue Plan partners, Prime used retrospective data and medical claims from a commercially insured population of 3.6 million members with eligibility between 2007 and 2009.

Of the 91,931 members that fit the inclusion criteria of hypertensive patient, 66.4 percent (61,040) were adherent and 33.6 percent (30,891) were not. The adherent group was associated with a lower hospitalization rate (10.1 percent adherent vs. 11.1 percent non-adherent), lower medical costs ($7,124 adherent versus $7,441 non-adherent), higher pharmacy costs ($3,079 adherent versus $1,733 non-adherent) and high total cost of care ($10,203 adherent versus $9,174 non-adherent).

"Hypertension medication is a
'/>"/>

SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
2. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in Miami
5. Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)
6. Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension
7. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
8. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
9. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension
11. Dong-A PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Foundation today announced it has established a relief fund ... weather that has gripped much of the nation. AARP and ... to support these emergency relief efforts AARP and AARP Foundation ... up to $500,000 in aid. The matching program will be ...
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
(Date:1/15/2014)... , January 15, 2014 BreedIT ... the exclusive worldwide distributor of highly sophisticated agro-breeding solutions ... January 7, 2014, the Company,s board of directors appointed ... as its new member of the board. ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
(Date:4/18/2014)... Hopkins University School of Medicine researchers have been awarded ... diabetes, Novo Nordisk announced this month. Of the 110 ... Obesity Biologics Science Forum Program, only four projects were ... researchers. They are Jonathan Powell, M.D., Ph.D.; G. William ... Jonathan Powell, a professor of oncology, will use his ...
(Date:4/18/2014)... release is available in French . ... revolutionize surgical practice and regenerative medicine. A team led ... Chimie (CNRS/ESPCI Paris Tech) and Didier Letourneur from the ... 13), has just demonstrated that the principle of adhesion ... vivo to repair soft-tissue organs and tissues. This easy-to-use ...
(Date:4/17/2014)... pain relief targets that could be used to ... King,s College London made the discovery when researching ... of the body. , Dr Marzia Malcangio said: ... pain generation and our findings could help chemotherapy ... One potential side effect of some chemotherapy drugs ...
(Date:4/17/2014)... Colo. (April 17, 2014) Two recent papers ... researcher and colleagues may help scientists develop treatments ... Yellow fever, Japanese encephalitis and other disease-causing flaviviruses. ... biochemistry and molecular genetics at the School of ... Howard Hughes Medical Institute, and colleagues recently published ...
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... - New Hayfever Relief Product Based on Acupressure ... , - With Photo , ... it,s believed that,it now affects as many as 1 in 4 ... either complete misery with symptoms such as reduced,concentration, runny nose and ...
... Improvement Firm Recognizes Efforts in Patient SatisfactionSOUTH BEND, Ind., ... Press Ganey Associates, Inc., is proud to recognize all ... improving the quality of care they provide."The doctors, nurses, ... to improve quality, and they deserve to be commended," ...
... urged to prevent head, neck injuries , , SUNDAY, May ... help prevent head and neck injuries related to recreational ... year in the United States, about 1.5 million people ... and nearly 12,000 are treated for neck fractures, according ...
... Support the Nancy Davis Foundation for Multiple Sclerosis LOS ... the world,s most exclusive super sport cars, donated the ... to support the Nancy Davis Foundation for Multiple Sclerosis ... charity event at the Hyatt Regency Century Plaza in ...
... thwart hospital ,superbugs, viruses and mold, scientists say ... paint kills disease-causing bacteria, mold, fungi and viruses, said ... claim their paint, which can be used in homes, ... so-called "superbugs," antibiotic-resistant microbes that are found in hospitals ...
... free workshops with an emphasis on smoking cessation to raise public ... in order to improve their quality of life. , ... ... consecutive year, May 2009 has been designated Stroke Awareness Month. During ...
Cached Medicine News:Health News:'Qu-Chi' Acupressure Band Gives Hayfever Misery the Elbow 2Health News:'Qu-Chi' Acupressure Band Gives Hayfever Misery the Elbow 3Health News:Press Ganey Supports National Hospital Week 2Health News:Press Ganey Supports National Hospital Week 3Health News:Ladders, Swings and More Can Cause Peril 2Health News:First U.S. Lamborghini Gallardo LP 560-4 Spyder Auctioned at Race to Erase MS Charity Event 2Health News:Health Care Professionals Offer Free Consultations for National Stroke Awareness Month 2
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
Finesse II electrosurgical generator (100-120 VAC) utilizes a patented design that integrates the electrosurgical generator and smoke evacuation system into a single compact unit....
... 950, the first High Frequency Desiccator with Cut. ... half of the unit is a high frequency ... popular Aaron 900. The other half is a ... power and coag capabilities plenty of power ...
Medicine Products: